(Q51017581)
Statements
Bortezomib ADDED to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials Group (English)
Laurie H Sehn
David MacDonald
Sheldon Rubin
Guy Cantin
Morel Rubinger
Bernard Lemieux
Sanraj Basi
Kevin Imrie
Jonathan Sussman
Marina Djurfeldt
Lois Shepherd
Stephen Couban
Michael Crump
1 August 2011